PharmaBoardroom

William (Wei) Cao – Founder, Chairman & CEO, Gracell,…

William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big…

Jin Woo Lee – Founder & CEO, YD Global Life Science,…

YD Global Life Science is a Korean biopharmaceutical company with ambitions to become a global leader in new drug development with USD 1 billion in…

Christine Placet – CEO, Horama, France

Christine Placet, CEO of French biotech Horama, discusses the objective of becoming one of the key players in the field of ophthalmic gene therapy.…

André Choulika – Chairman & CEO, Cellectis, France

André Choulika, Chairman and CEO of Cellectis, discusses how UCART will revolutionize cell therapy as a universal gene-edited solution as opposed to…

Jun Bao – President & CEO, Impact Therapeutics, China

Dr Jun Bao, appointed president and CEO of Impact Therapeutics in October 2018, shares his aspirations for Impact to be a leader in synthetic…

John Yu – CEO, CGeneTech, China

Dr John Yu, co-founder and CEO of CGeneTech, shares the exciting story behind the company’s establishment in 2010; its balanced philosophy on new…

David Kim – CEO, Cure Therapeutics & CureCell, South…

Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative…

Samantha Du – Chairman & CEO, Zai Lab, China

Samantha Du, Chairman and CEO of Zai Lab, the flagship China biotech company, shares her inspirational story of being one of the pioneers to forge a…

James Jungkue Lee – Founder & CEO, Bridge…

James Jungkue Lee, founder and CEO of Bridge Biotherapeutics, explains his strategy for risk mitigation in running a virtual biotech start-up. He also…